Operating Margin

A new report slams the FDA for blocking vital treatments with rising costs and denials, but the agency faces a complex reality of reform and internal pressure.

A record $606.5M net income, fueled by a major divestment, funds a $200M dividend and a strategic merger creating a global IT powerhouse.

With its 32nd straight dividend hike and a $100M buyback, Wiley leverages strong Q3 results and AI momentum to underscore its financial health.

Just years after mass closures, Metroland is betting on a new monthly print model to revive local journalism and fight misinformation. Is this a new era?

Despite revenue growth, ICAPE Group posts a net loss after deciding to close two plants, signaling a pivot to a leaner model focused on innovation.

As big banks retreat, private lenders and small investors are revitalizing neighborhoods and adding homes to a market in desperate need of supply.

The smart glasses maker reports record sales driven by niche products, yet continued investment in global expansion keeps the company in the red for now.

Facing a historic downturn and geopolitical turmoil, the chemical industry gathers in Texas to debate its strategy for survival and transformation.

As safety tech fills our roads, Autel's newly ASE and I-CAR accredited ADAS program aims to fix a critical skills gap and ensure vehicle safety.

Noah Holdings reports a surge in profitability, driven by AI-led efficiencies and a global pivot, rewarding shareholders with 100% of its net income.

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?

Rithm Capital declared its 52nd straight dividend. Is its high yield and analyst praise enough to overcome recent stock woes and market skepticism?

Investors await East Side Games Group's year-end results to see if a costly Q3 investment in new titles will finally pay off and reverse recent losses.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

A Vancouver firm's revolutionary tech, backed by government funds, aims to decarbonize metal recovery and secure North America's platinum supply chain.

Capstone Holding Corp. merges Midwest operations, targeting positive EBITDA by 2026 amid major project wins and a disciplined cost-cutting campaign.

The non-prime lender struck a deal with lenders to ensure liquidity, but it comes at a high price amid massive loan losses and scrutiny of its LendCare unit.

Investors eye Cardinal Health's April 30 report for signs its aggressive diversification and specialty pharma push can sustain its powerful earnings momentum.

Two major US investors build significant stakes in AI-native platform Sidetrade, signaling a wider trend of American capital chasing European tech innovation.

Vodafone Germany partners with Aurora Networks and HUBER+SUHNER to build a multi-gigabit network, slashing costs and boosting speeds for millions.